Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

Pulmonary Embolism I: Introduction

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Violation detection in power operation sites based on multi-scale detection and few-shot learning.

Frontiers in artificial intelligence·2026

Same author

Interpreting the Economic Value of TPEx in Recurrent or Metastatic HNSCC: The Importance of Decision Context, Utility Timing, and Treatment Burden.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Same author

Association between Impaired Lung Function and Pulmonary Perfusion Defects Assessed by Phase-resolved Functional Lung MRI.

Radiology. Cardiothoracic imaging·2026

Same author

Beyond the Base Case: Payment Perspective and Ductal Carcinoma In Situ Management Assumptions in Artificial-Intelligence-Assisted Breast Screening Models.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Same author

Potential factors influencing quality of life in Chinese adult women with urinary incontinence: a nationwide cross-sectional study.

World journal of urology·2026

Same author

Machine learning and SHAP interpretation for predicting coronary heart disease-diabetes comorbidity with dietary antioxidants.

Scientific reports·2026

Search research articles

Related Experiment Video

Updated: May 29, 2026

Isolation, Characterization, and Proteomic Analysis of Plasma-Derived Extracellular Vesicles for Cardiovascular Biomarker Discovery

Isolation, Characterization, and Proteomic Analysis of Plasma-Derived Extracellular Vesicles for Cardiovascular Biomarker Discovery

Published on: January 31, 2025

Elevated plasma pentraxin 3: a potential cardiovascular risk factor?

Qiming Liu¹, Tao Tu, Zhongle Bai

¹Department of Cardiology, Second Xiangya Hospital, Central South University, Renmin Road 139, Changsha 410011, PR China. qimingxiangya@gmail.com

Medical Hypotheses

|September 28, 2011

Summary

This summary is machine-generated.

Elevated pentraxin 3 (PTX3) levels may indicate cardiovascular disease risk. This innate immune protein is linked to poor cardiovascular outcomes and could be a therapeutic target.

Related Experiment Videos

Last Updated: May 29, 2026

Isolation, Characterization, and Proteomic Analysis of Plasma-Derived Extracellular Vesicles for Cardiovascular Biomarker Discovery

Isolation, Characterization, and Proteomic Analysis of Plasma-Derived Extracellular Vesicles for Cardiovascular Biomarker Discovery

Published on: January 31, 2025

Area of Science:

Immunology
Cardiology
Biochemistry

Background:

Cardiovascular disease (CVD) remains a leading cause of mortality globally.
The innate immune system, including pentraxins, is increasingly implicated in CVD pathogenesis.
Elevated plasma pentraxin 3 (PTX3) shows associations with cardiovascular events and risk factors.

Purpose of the Study:

To investigate the hypothesis that elevated plasma PTX3 is a potential cardiovascular risk factor.
To explore the role of PTX3 in angiogenesis, restenosis, and atherosclerotic lesion development.
To correlate plasma PTX3 levels with adverse cardiovascular outcomes in patients.

Main Methods:

Review of recent research on PTX3 expression and function in cardiovascular contexts.
Analysis of studies linking PTX3 to angiogenesis inhibition and restenosis.
Examination of PTX3 expression in atherosclerotic lesions and patient blood samples.
Correlation analysis of plasma PTX3 levels with cardiovascular outcomes.

Main Results:

PTX3 was found to inhibit angiogenesis and promote restenosis.
Increased PTX3 expression was observed in advanced atherosclerotic lesions and in the blood of patients with ischemic heart disorders.
Elevated plasma PTX3 levels correlated with adverse cardiovascular outcomes.

Conclusions:

Elevated plasma PTX3 is a potential cardiovascular risk factor.
PTX3 may play a significant role in the development and progression of cardiovascular disease.
PTX3 represents a potential therapeutic target for CVD prevention and treatment.